NEWTON, Mass.--(BUSINESS WIRE)--Clinical Data, Inc. (NASDAQ:CLDA) announced at the Heart Rhythm Society’s annual meeting, 2008 Heart Rhythm, that its PGxHealthTM division is adding genetic testing for Hypertrophic Cardiomyopathy (HCM) to its FAMILION® family of genetic tests for cardiac syndromes.
